References
- 1. Larroque B, Bréart G, Kaminski M, et al. Survival of very preterm infants: Epipage, a population based cohort study. Arch Dis Child – Fetal Neonatal Ed. 2004;89(2):F139–44.
- 2. Berrington JE, Hearn RI, Bythell M et al. Deaths in Preterm Infants: Changing Pathology Over 2 Decades. J Pediatr. 2012;160(1):49-53.e1.
- 3. Alsaied A, Islam N, Thalib L. Global incidence of Necrotizing Enterocolitis: a systematic review and Meta-analysis. BMC Pediatr. 2020;20(1):344.
- 4. Embleton ND, Skeath T. Probiotics for preterm infants on the NICU. Paediatr Child Health. 2014;24(1):38-40.
- 5. Guner YS, Friedlich P, Wee CP et al. State-Based Analysis of Necrotizing Enterocolitis Outcomes1. J Surg Res. 2009;157(1):21-9.
- 6. Ma B, McComb E, Gajer P, et al. Microbial Biomarkers of Intestinal Barrier Maturation in Preterm Infants. Front Microbiol. 2018;9:2755. doi: 10.3389/fmicb.2018.02755.
- 7. Battersby C, Santhalingam T, Costeloe K, Modi N. Incidence of neonatal necrotising enterocolitis in high-income countries: a systematic review. Arch Dis Child – Fetal Neonatal Ed. 2018;103(2):F182-9.
- 8. Overman RE, Criss CN, Gadepalli SK. Necrotizing enterocolitis in term neonates: A different disease process? J Pediatr Surg. 2019;54(6):1143-6.
- 9. Cuna A, George L, Sampath V. Genetic predisposition to necrotizing enterocolitis in premature infants: Current knowledge, challenges, and future directions. Semin Fetal Neonatal Med. 2018;23(6):387-93.
- 10. Bergmann KR, Liu SXL, Tian R, et al. Bifi dobacteria Stabilize Claudins at Tight Junctions and Prevent Intestinal Barrier Dysfunction in Mouse Necrotizing Enterocolitis. Am J Pathol. 2013;182(5):1595-606.
- 11. Turroni F, Peano C, Pass DA, et al. Diversity of Bifi dobacteria within the Infant Gut Microbiota. PLoS ONE. 2012;7(5):e36957.
- 12. Arboleya S, Binetti A, Salazar N, et al. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol Ecol. 2012;79(3):763-72.
- 13. Lopetuso LR, Scaldaferri F, Petito V, Gasbarrini A. Commensal Clostridia: leading players in the maintenance of gut homeostasis. Gut Pathog. 2013;5(1):23.
- 14. Patel RM, Kandefer S, Walsh MC, et al. Causes and Timing of Death in Extremely Premature Infants from 2000 through 2011. N Engl J Med. 2015;372(4):331-40.
- 15. Derrien M, van Hylckama Vlieg JET. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 2015;23(6):354-66.
- 16. Walker WA. Mechanisms of Action of Probiotics. Clin Infect Dis. 2008 1;46(Supplement 2):S87-91.
- 17. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489(7415):242-9.
- 18. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701-12.
- 19. Sanders ME, Akkermans LM, Haller D, et al. Safety assessment of probiotics for human use. Gut Microbes. 2010;1(3):164-85.
- 20. Cukrowska B, Bierła JB, Zakrzewska M et al. The Relationship between the Infant Gut Microbiota and Allergy. The Role of Bifi dobacterium breve and Prebiotic Oligosaccharides in the Activation of Anti-Allergic Mechanisms in Early Life. Nutrients. 2020;12(4):946.
- 21. Vincent D, Klinke M, Eschenburg G, et al. NEC is likely a NETs dependent process and markers of NETosis are predictive of NEC in mice and humans. Sci Rep. 2018;8(1):12612.
- 22. Boudry G, Charton E, Le Huerou-Luron I, et al. The Relationship Between Breast Milk Components and the Infant Gut Microbiota. Front Nutr. 2021;8:629740. doi: 10.3389/fnut.2021.629740.
- 23. Le Doare K, Holder B, Bassett A, Pannaraj PS. Mother’s Milk: A Purposeful Contribution to the Development of the Infant Microbiota and Immunity. Front Immunol. 2018;9:361. doi: 10.3389/fimmu.2018.00361.
- 24. Khodayar-Pardo P, Mira-Pascual L, Collado MC, Martínez-Costa C. Impact of lactation stage, gestational age and mode of delivery on breast milk microbiota. J Perinatol. 2014;34(8):599-605.
- 25. Green-Johnson JM. Immunological Responses to Gut Bacteria. J AOAC Int. 2012;95(1):35-49.
- 26. Caselli M, Cassol F, Calò G et al. Actual concept of “probiotics”: Is it more functional to science or business? World J Gastroenterol. 2013;19(10):1527-40.
- 27. Sanna S, van Zuydam NR, Mahajan A, et al. Causal relationships between gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet. 2019;51(4):600-5.
- 28. Kien CL, McClead RE, Cordero L. Effects of lactose intake on lactose digestion and colonic fermentation in preterm infants. J Pediatr. 1998;133(3):401-5.
- 29. Blouin JM, Penot G, Collinet M, et al. Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex. Int J Cancer. 2011;128(11):2591-601.
- 30. Nafday SM, Chen W, Peng L et al. Short-Chain Fatty Acids Induce Colonic Mucosal Injury in Rats with Various Postnatal Ages. Pediatr Res. 2005;57(2):201-4.
- 31. Brooks B, Firek BA, Miller CS, et al. Microbes in the neonatal intensive care unit resemble those found in the gut of premature infants. Microbiome. 2014;2(1):1.
- 32. Wittrock B, Lavin MA, Pierry D et al. Parents as a Vector for Nosocomial Infection in the Neonatal Intensive Care Unit. Infect Control Hosp Epidemiol. 2001;22(08):472.
- 33. Kaufman D, Blackman A, Conaway MR, Sinkin RA. Nonsterile glove use in addition to hand hygiene to prevent late-onset infection in preterm infants: randomized clinical trial. JAMA Pediatr. 2014;168(10):909-16.
- 34. Indrio F, Salatto A, Amato O, et al. COVID-19 pandemic in the neonatal intensive care unit: any effect on late-onset sepsis and necrotizing enterocolitis? Eur J Pediatr. 2022;181(2):853-7.
- 35. Ergenekon E, Tayman C, Özkan H. Turkish Neonatal Society Necrotizing Enterocolitis Diagnosis, Treatment and Prevention Guidelines. Turk Arch Pediatr. 2021;56(5):513-524.
- 36. Bell MJ, Ternberg JL, Feigin RD et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1-7.
- 37. Kim JH, Sampath V, Canvasser J. Challenges in diagnosing necrotizing enterocolitis. Pediatr Res. 2020;88(1):16-20.
- 38. Juhl SM, Hansen ML, Gormsen M et al. Staging of necrotising enterocolitis by Bell’s criteria is supported by a statistical pattern analysis of clinical and radiological variables. Acta Paediatr Oslo Nor (1992). 2019;108(5):842-8.
- 39. World Health Organization. WHO recommendations on interventions to improve preterm birth outcomes: evidence base [Internet]. Geneva: World Health Organization; 2015 [cited 2022 May 16]. Available from: https://apps.who.int/iris/handle/10665/183038
- 40. Patole S. Prevention and treatment of necrotising enterocolitis in preterm neonates. Early Hum Dev. 2007;83(10):635-42.
- 41. Parker MG, Stellwagen LM, Noble L et al. Promoting Human Milk and Breastfeeding for the Very Low Birth Weight Infant. Pediatrics. 2021;148(5):e2021054272.
- 42. Barbian ME, Buckle R, Denning PW, Patel RM. To start or not: Factors to consider when implementing routine probiotic use in the NICU. Early Hum Dev. 2019; 135:66-71.
- 43. Manzoni P, Meyer M, Stolfi I, et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Hum Dev. 2014;90:S60-5.
- 44. Griffiths J, Jenkins P, Vargova M, et al. Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial. The Lancet. 2019;393(10170):423-33.
- 45. Manzoni P. Clinical Benefits of Lactoferrin for Infants and Children. J Pediatr. 2016; 173:S43-52.
- 46. Sharma R, Tepas JJ, Mollitt DL et al. Surgical management of bowel perforations and outcome in very low-birth-weight infants (< or =1,200 g). J Pediatr Surg. 2004;39(2):190-4.
- 47. Athalye-Jape G, Patole S. Probiotics for preterm infants – time to end all controversies. Microb Biotechnol. 2019;12(2):249-53.
- 48. Neu J. Probiotics and Necrotizing Enterocolitis. Clin Perinatol. 2014;41(4):967-78.
- 49. Katan MB. Why the European Food Safety Authority was right to reject health claims for probiotics. Benef Microbes. 2012;3(2):85-9.
- 50. Core Team R. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna Austria URL Https:www R-Proj OrgGoogle Sch. 2021
- 51. RStudio Team. RStudio: Integrated Development Environment for R [Internet]. Boston, MA: RStudio, PBC.; 2021. Available from: http://www.rstudio.com/
- 52. Aria M, Cuccurullo C. bibliometrix: An R-tool for comprehensive science mapping analysis. J Informetr. 2017;11(4):959-75.
- 53. A brief introduction to bibliometrix [Internet]. BIBLIOMETRIX. Available from: https://www.bibliometrix.org/vignettes/Introduction_to_bibliometrix.html
- 54. Millar MR, Bacon C, Smith SL et al. Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child. 1993 Nov;69(5 Spec No):483-7.
- 55. Kitajima H, Sumida Y, Tanaka R et al. Early administration of Bifi dobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 1997 Mar;76(2):F101-7
- 56. Grönlund MM, Lehtonen OP, Kent P et al. Erratum.: Lactobacillus GG supplementation does not reduce faecal colonization of Klebsiella oxytoca in preterm infants. Acta Paediatr. 1997;86(7):785-6.
- 57. Dani C, Biadaioli R, Bertini G et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate. 2002 Aug;82(2):103-8.
- 58. Costalos C, Skouteri V, Gounaris A et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev. 2003; 74(2):89-96.
- 59. Lin HC, Su BH, Chen AC, et al. Oral Probiotics Reduce the Incidence and Severity of Necrotizing Enterocolitis in Very Low Birth Weight Infants. Pediatrics. 2005;115(1):1-4.
- 60. Jacobs SE, Tobin JM, Opie GF, et al. Probiotic Effects on Late-onset Sepsis in Very Preterm Infants: A Randomized Controlled Trial. Pediatrics. 2013;132(6):1055-62.
- 61. Costeloe K, Hardy P, Juszczak E et al. Bifi dobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. The Lancet. 2016;387(10019):649-60.
- 62. Zbinden A, Zbinden R, Berger C, Arlettaz R. Case Series of Bifi dobacterium longum Bacteremia in Three Preterm Infants on Probiotic Therapy. Neonatology. 2015;107(1):56-9.
- 63. Van den Akker CHP, Van Goudoever JB, Shamir R, et al. Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr. 2020;70(5):664-80.
- 64. Manzoni P, Mostert M, Leonessa ML, et al. Oral Supplementation with Lactobacillus casei Subspecies rhamnosus Prevents Enteric Colonization by Candida Species in Preterm Neonates: A Randomized Study. Clin Infect Dis. 2006;42(12):1735-42.
- 65. Rougé C, Piloquet H, Butel MJ et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2009;89(6):1828-35.
- 66. Mihatsch WA, Vossbeck S, Eikmanns B et al. Effect of Bifidobacterium lactis on the Incidence of Nosocomial Infections in Very-Low-Birth-Weight Infants: A Randomized Controlled Trial. Neonatology. 2010;98(2):156-63.
- 67. Stratiki Z, Costalos C, Sevastiadou S, et al. The effect of a bifi dobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev. 2007;83(9):575-9.
- 68. Mohan R, Koebnick C, Schildt J et al. Effects of Bifi dobacterium lactis Bb12 Supplementation on Body Weight, Fecal pH, Acetate, Lactate, Calprotectin, and IgA in Preterm Infants. Pediatr Res. 2008;64(4):418-22.
- 69. Sari FN, Dizdar EA, Oguz S et al. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr. 2011;65(4):434-9.
- 70. Braga TD, da Silva GAP, de Lira PIC et al. Efficacy of Bifi dobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr. 2011;93(1):81-6.
- 71. Rojas MA, Lozano JM, Rojas MX, et al. Prophylactic Probiotics to Prevent Death and Nosocomial Infection in Preterm Infants. Pediatrics. 2012;130(5):e1113-20.
- 72. Esaiassen E, Cavanagh P, Hjerde E et al. Bifi dobacterium longum Subspecies infantis Bacteremia in 3 Extremely Preterm Infants Receiving Probiotics. Emerg Infect Dis. 2016;22(9):1664-6.
- 73. Borriello SP, Hammes WP, Holzapfel W, et al. Safety of Probiotics That Contain Lactobacilli or Bifi dobacteria. Clin Infect Dis. 2003;36(6):775-80.
- 74. Bury S, Soundararajan M, Bharti R et al. The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ. Front Microbiol. 2018;9:929.
- 75. Jenke A, Ruf EM, Hoppe T et al. Bifi dobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy. Arch Dis Child Fetal Neonatal Ed. 2012;97(3):F217-218.
- 76. Dani C, Coviello CC, Corsini II et al. Lactobacillus Sepsis and Probiotic Therapy in Newborns: Two New Cases and Literature Review. AJP Rep. 2016;6(1):e25-9.
- 77. Mack DR. D(—)–Lactic Acid Producing Probiotics, D(—)–Lactic Acidosis and Infants. Can J Gastroenterol. 2004;18(11):671-5.
- 78. Shida K, Nanno M, Nagata S. Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: A possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes. 2011;2(2):109–14.
- 79. Lutgendorff F, Trulsson LM, Minnen LP et al. Probiotics enhance pancreatic glutathione biosynthesis and reduce oxidative stress in experimental acute pancreatitis. Am J Physiol – Gastrointest Liver Physiol. 2008;295(5):G1111-21.
- 80. European Medicines Agency. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) – saccharomyces boulardii. 2020.
- 81. Lin HY, Chang JH, Chung MY, Lin HC. Prevention of necrotizing enterocolitis in preterm very low birth weight infants: Is it feasible? J Formos Med Assoc. 2014;113(8):490-7.
- 82. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2011;(3):CD005496. doi: 10.1002/14651858.CD005496.pub3. Update in: Cochrane Database Syst Rev. 2014;4:CD005496.
- 83. Deshpande GC, Rao SC, Keil AD, Patole SK. Evidencebased guidelines for use of probiotics in preterm neonates. BMC Med. 2011;9:92.
- 84. Van den Akker CHP, Van Goudoever JB, Szajewska H et al. Probiotics for Preterm Infants: A Strain-Specific Systematic Review and Network Meta-analysis. J Pediatr Gastroenterol Nutr. 2018;67(1):103-22.
- 85. Poindexter B, Committee On fetus and newborn, Cummings J, Hand I, Adams-Chapman et al. Use of Probiotics in Preterm Infants. Pediatrics. 2021 Jun 1;147(6):e2021051485.
- 86. Juber BA, Boly TJ, Pitcher GJ, McElroy SJ. Routine Administration of a Multispecies Probiotic Containing Bifidobacterium and Lactobacillus to Very Low Birth Weight Infants Had No Significant Impact on the Incidence of Necrotizing Enterocolitis. Front Pediatr. 2021;9:757299. doi: 10.3389/fped.2021.757299.
- 87. Bhadoria P, Mahapatra S. Prospects, technological aspects and limitations of probiotics–a worldwide review. Eur J Food Res Rev. 2011;1(2):23-42.
- 88. Ritchie ML, Romanuk TN. A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases. 2012;7(4):e34938. doi: 10.1371/journal.pone.0034938.
- 89. Binns N. Probiotics, prebiotics and the gut microbiota. Brussels: ILSI Europe; 2013.
- 90. Licht TR, Baggesen DL. EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2013. Scientific Opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2013 update). European Food Safety Authority; 2013.
- 91. Lewis ZT, Shani G, Masarweh CF, et al. Validating bifi dobacterial species and subspecies identity in commercial probiotic products. Pediatr Res. 2016;79(3):445-52.
- 92. Vallabhaneni S, Walker TA, Lockhart SR, et al. Fatal Gastrointestinal Mucormycosis in a Premature Infant Associated with a Contaminated Dietary Supplement – Connecticut, 2014. Morb Mortal Wkly Rep. 2015;64(6):155-6.
- 93. Georgieva M, Andonova L, Peikova L, Zlatkov A. Probiotics – Health Benefits, Classification, Quality Assurance аnd Quality Control – Review. Pharmacia. 2014; 61(4):22-31.